Matthew J Girgenti1, Brendan D Hare1, Sriparna Ghosal1, Ronald S Duman2. 1. Department of Psychiatry, Laboratory of Molecular Psychiatry, Center for Genes and Behavior, Yale University School of Medicine, New Haven, CT, 06508, USA. 2. Department of Psychiatry, Laboratory of Molecular Psychiatry, Center for Genes and Behavior, Yale University School of Medicine, New Haven, CT, 06508, USA. Ronald.duman@yale.edu.
Abstract
PURPOSE OF REVIEW: Posttraumatic stress disorder (PTSD) is characterized by hyperarousal and recurrent stressful memories after an emotionally traumatic event. Extensive research has been conducted to identify the neurobiological determinants that underlie the pathophysiology of PTSD. In this review, we examine evidence regarding the molecular and cellular pathophysiology of PTSD focusing on two primary brain regions: the vmPFC and the amygdala. RECENT FINDINGS: This discussion includes a review of the molecular alterations related to PTSD, focusing mainly on changes to glucocorticoid receptor signaling. We also examine postmortem gene expression studies that have been conducted to date and the molecular changes that have been observed in peripheral blood studies of PTSD patients. Causal, mechanistic evidence is difficult to obtain in human studies, so we also review preclinical models of PTSD. Integration of peripheral blood and postmortem studies with preclinical models of PTSD has begun to reveal the molecular changes occurring in patients with PTSD. These findings indicate that the pathophysiology of PTSD includes disruption of glucocorticoid signaling and inflammatory systems and occurs at the level of altered gene expression. We will assess the impact of these findings on the future of PTSD molecular research.
PURPOSE OF REVIEW: Posttraumatic stress disorder (PTSD) is characterized by hyperarousal and recurrent stressful memories after an emotionally traumatic event. Extensive research has been conducted to identify the neurobiological determinants that underlie the pathophysiology of PTSD. In this review, we examine evidence regarding the molecular and cellular pathophysiology of PTSD focusing on two primary brain regions: the vmPFC and the amygdala. RECENT FINDINGS: This discussion includes a review of the molecular alterations related to PTSD, focusing mainly on changes to glucocorticoid receptor signaling. We also examine postmortem gene expression studies that have been conducted to date and the molecular changes that have been observed in peripheral blood studies of PTSDpatients. Causal, mechanistic evidence is difficult to obtain in human studies, so we also review preclinical models of PTSD. Integration of peripheral blood and postmortem studies with preclinical models of PTSD has begun to reveal the molecular changes occurring in patients with PTSD. These findings indicate that the pathophysiology of PTSD includes disruption of glucocorticoid signaling and inflammatory systems and occurs at the level of altered gene expression. We will assess the impact of these findings on the future of PTSD molecular research.
Authors: Marie-Louise Meewisse; Johannes B Reitsma; Giel-Jan de Vries; Berthold P R Gersons; Miranda Olff Journal: Br J Psychiatry Date: 2007-11 Impact factor: 9.319
Authors: Michael Koenigs; Edward D Huey; Vanessa Raymont; Bobby Cheon; Jeffrey Solomon; Eric M Wassermann; Jordan Grafman Journal: Nat Neurosci Date: 2007-12-23 Impact factor: 24.884
Authors: Adriana Feder; Michael K Parides; James W Murrough; Andrew M Perez; Julia E Morgan; Shireen Saxena; Katherine Kirkwood; Marije Aan Het Rot; Kyle A B Lapidus; Le-Ben Wan; Dan Iosifescu; Dennis S Charney Journal: JAMA Psychiatry Date: 2014-06 Impact factor: 21.596
Authors: Heather L Rusch; Jeffrey Robinson; Sijung Yun; Nicole D Osier; Christiana Martin; Chris R Brewin; Jessica M Gill Journal: Brain Behav Immun Date: 2019-04-27 Impact factor: 7.217
Authors: Sonalee A Joshi; Elizabeth R Duval; Jony Sheynin; Anthony P King; K Luan Phan; Brian Martis; Katherine E Porter; Israel Liberzon; Sheila A M Rauch Journal: Psychiatry Res Neuroimaging Date: 2020-03-05 Impact factor: 2.493
Authors: Pramod R Somvanshi; Synthia H Mellon; Janine D Flory; Duna Abu-Amara; Owen M Wolkowitz; Rachel Yehuda; Marti Jett; Leroy Hood; Charles Marmar; Francis J Doyle Journal: Am J Physiol Endocrinol Metab Date: 2019-07-19 Impact factor: 4.310
Authors: Moustafa Algamal; Joseph O Ojo; Carlyn P Lungmus; Phillip Muza; Constance Cammarata; Margaret J Owens; Benoit C Mouzon; David M Diamond; Michael Mullan; Fiona Crawford Journal: Front Behav Neurosci Date: 2018-07-20 Impact factor: 3.558